It has not been approved for any clinical indication in humans
BPC-157 Vial Research Peptide KLOW BLEND Vial Research Peptide TB-500 Vial Research Peptide GHK-CU Vial Research Peptide Liever direct aan de slag
Each lot is verified by an independent lab before it's listed: ultra-high-performance liquid chromatography with mass spectrometry (UPLC/MS), assayed for purity against a 99% release specification and for molecular weight to confirm identity
doi:10.4103/1008-682x.179252
"BPC" stands for "Body Protection Compound." In preclinical work it is proposed to act through several overlapping pathways, including promotion of new blood-vessel growth (angiogenesis), modulation of nitric-oxide signaling, and anti-inflammatory activity, rather than through one well-defined receptor mechanism the way a conventional small-molecule drug does
Safety FDA found no clinical studies establishing safety, no pharmacokinetic data and no human immunogenicity or aggregation studies